知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

3 条记录 (耗时 0.043 秒)

    Transparent antenna
    1.
    发明授权
    Transparent antenna 有权
    透明天线

    公开(公告)号：US09537216B1

    公开(公告)日：2017-01-03

    申请号：US14306541

    申请日：2014-06-17

    申请人： George Kontopidis ,  R Brough Turner

    发明人： George Kontopidis ,  R Brough Turner

    IPC分类号： H01Q3/00 ,  H01Q3/36 ,  H01Q21/00

    CPC分类号： H01Q3/36 ,  H01Q1/1271 ,  H01Q3/26 ,  H01Q21/0006 ,  H01Q21/065

    摘要： Antenna arrays can be fabricated as patches on conductive transparent material over an appropriate transparent dielectric substrate with the appropriate transparent ground-plane. To keep the fabrication cost low, such antenna arrays have a planar design without cross-over of the feeding lines or 3D interconnects. To steer the antenna horizontally, patches need to be fed with incremental phase shifts relative to their left or right neighbors; such feeds require an appropriate network and RF switches, typically located in an adjacent non-transparent area such as a PCB. Fabricating and disposing transparent phase delay component on the transparent material reduces the size of the PCB, thereby increasing visible transparent area.

    摘要翻译： 天线阵列可以在具有适当的透明接地平面的合适的透明电介质基底上制成导电透明材料上的贴片。 为了保持制造成本低，这样的天线阵列具有平面设计，而不会与馈线或3D互连交叉。 为了水平地引导天线，补片需要相对于它们的左或右邻居进行增量相移; 这样的馈送需要适当的网络和RF开关，通常位于相邻的非透明区域（例如PCB）中。 在透明材料上制造和布置透明相位延迟元件会减小PCB的尺寸，从而增加可见的透明面积。

    Cyclin groove inhibitors
    2.
    发明申请
    Cyclin groove inhibitors 审中-公开

    公开(公告)号：US20060281687A1

    公开(公告)日：2006-12-14

    申请号：US11408905

    申请日：2006-04-21

    申请人： Martin Andrews ,  Campbell McInnes ,  George Kontopidis ,  Peter Fischer

    发明人： Martin Andrews ,  Campbell McInnes ,  George Kontopidis ,  Peter Fischer

    IPC分类号： A61K38/08 ,  C07K7/06

    CPC分类号： C07K14/4738 ,  A61K38/00 ,  G01N33/5011 ,  G01N33/6872 ,  G01N2333/4739 ,  G01N2333/91205 ,  G01N2500/02

    摘要： The present invention relates to a compound of formula I, or a variant thereof, A-(B)m-C-(D)n-E  (I)wherein m and n are each independently 0 or 1 and A, B, C, D and E are each independently linked to the respective adjacent residue by a linker group independently selected from carboxamide, reduced carboxamide, sulfonamide, imine, semicarbazone, oxime and ethanolamine; A is (i) a natural or unnatural amino acid residue having a side chain comprising at least one H-bond acceptor moiety and at least one H-bond donor moiety, or a derivative thereof; or (ii) R(CO), wherein R is a C1-C24 hydrocarbyl group comprising at least one H-bond acceptor moiety and optionally one or more H-bond donor moieties, and where R optionally contains one or more heteroatoms selected from S, O, and N, and is optionally substituted by one or more substituents selected from halogen, OMe, CN, CF3, and NO2; each of B and D is independently an amino acid residue selected from arginine, 4-(guanidinyl)phenylalanine (4-(Gu)Phe), piperidinylglycine (PipGly), piperidinylalanine (PipAla), pyridinylalanine, histamine, N,N-(dimethyl) lysine (DMLys), citrulline, glutamine, serine, lysine, asparagine, isoleucine and alanine, or a derivative thereof; C is NH—X—CO, where X is a C1-C4 alkylene group substituted by a straight-chain or branched C1-C6 alkylene group, said C1-C6 alkylene group optionally containing a H-bond donor or H-bond acceptor moiety; E is (i) a natural or unnatural amino acid residue having an aryl or heteroaryl side chain, or a derivative thereof; or (ii) NHR′, where R′ is a C1-C24 hydrocarbyl group, optionally containing one or more heteroatoms selected from N, O, and S, and optionally comprising one or more H-bond acceptor or donor moieties; said hydrocarbyl group further comprising a pendent C4-C12 aryl or heteroaryl group, which itself may be optionally substituted by one or more substituents selected from a H-bond donor moiety, a H-bond acceptor moiety, a halogen, Me, Et, iPr, CF3, CN and NO2; wherein at least one of A and E is other than a natural or unnatural amino acid residue when A, B, C, D and E are each linked to the respective adjacent residue by a carboxamide group.